Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Azathioprine
Drug ID BADD_D00195
Description Azathioprine is a prodrug of 6-mercaptopurine, first synthesized in 1956 by Gertrude Elion, William Lange, and George Hitchings in an attempt to produce a derivative of 6-mercaptopurine with a better therapeutic index.[A189678,A189687,A189690] Azathioprine is used to treat inflammatory conditions like rheumatoid arthritis and as an immunosuppressant in the prevention of renal transplant rejection.[L11214] Azathiprine was granted FDA approval on 20 March 1968.[L11214]
Indications and Usage Anstey A, Lear JT: Azathioprine: clinical pharmacology and current indications in autoimmune disorders. BioDrugs. 1998 Jan;9(1):33-47.
Marketing Status Prescription; Discontinued
ATC Code L04AX01
DrugBank ID DB00993
KEGG ID D00238
MeSH ID D001379
PubChem ID 2265
TTD Drug ID D07QCE
NDC Product Code 72789-129; 51407-182; 46014-1110; 62991-2189; 12780-0300; 51927-2258; 48954-909; 51552-0779; 15308-0732; 42973-143; 68382-120; 38779-0312; 68382-119; 67877-492; 70771-1139; 65649-241; 68382-118; 67877-494; 54766-590; 68462-502; 0378-1005; 71610-124; 60219-2036; 70771-1140; 51927-0071; 65841-602; 68382-003; 71610-306; 42291-071; 60219-2037; 68084-229; 60219-1076; 70771-1141; 49452-0783; 65649-231; 67877-495; 67877-493; 66122-0009
Synonyms Azathioprine | Azothioprine | Imurel | Imuran | Immuran | Azathioprine Sodium | Sodium, Azathioprine | Azathioprine Sodium Salt | Azathioprine Sulfate
Chemical Information
Molecular Formula C9H7N7O2S
CAS Registry Number 446-86-6
SMILES CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anaphylactic shock10.01.07.002; 24.06.02.0040.002154%Not Available
Anastomotic ulcer07.04.04.003; 12.02.03.0010.002872%
Aneurysm24.02.01.0010.001436%Not Available
Angina pectoris02.02.02.002; 24.04.04.002--
Angiocentric lymphoma01.11.04.002; 16.17.04.0020.001124%Not Available
Anorectal disorder07.03.01.0010.002154%Not Available
Anxiety19.06.02.002--
Aortic stenosis24.04.01.0010.001436%Not Available
Aphasia17.02.03.001; 19.21.01.001--
Aphthous ulcer07.05.06.0020.003590%Not Available
Aplasia pure red cell01.03.03.001; 10.02.01.0030.007898%Not Available
Aplastic anaemia01.03.03.0020.000749%Not Available
Apnoea22.02.01.0010.002154%
Appendicitis07.19.01.001; 11.01.07.0010.003590%
Arrhythmia02.03.02.001--Not Available
Arthralgia15.01.02.0010.035900%
Arthritis15.01.01.0010.002872%
Arthropathy15.01.01.0030.002872%Not Available
Ascites02.05.04.002; 07.07.01.001; 09.01.05.0030.010770%
Aspartate aminotransferase increased13.03.01.0060.005744%
Asthenia08.01.01.0010.028002%Not Available
Asthma10.01.03.010; 22.03.01.0020.002872%Not Available
Atelectasis22.01.02.0010.001436%
Atrial fibrillation02.03.03.002--
Atrial septal defect02.04.02.009; 03.07.02.0020.007180%Not Available
Atypical pneumonia11.01.09.012; 22.07.01.0100.000749%Not Available
B-cell lymphoma01.15.01.001; 16.28.01.0010.002060%Not Available
Back pain15.03.04.005--
Bacteraemia11.01.11.0010.000562%
Basal cell carcinoma16.03.02.001; 23.08.02.0010.007898%Not Available
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 27 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene